Loading...
Lessons learned from cancer vaccine trials and target antigen choice
A wide variety of tumor antigens have been targeted in cancer immunotherapy studies. Traditionally, the focus has been on commonly overexpressed antigens shared across many patients and/or tumor types. As the field has progressed, the identity of human tumor rejection antigens has broadened. Immunol...
Na minha lista:
| Udgivet i: | Cancer Immunol Immunother |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4919159/ https://ncbi.nlm.nih.gov/pubmed/26842127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1801-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|